In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma (HCC), the time to HCC recurrence and the effects of sustained viral eradication (SVR) by interferon (IFN)-based or IFN-free regimens on HCC recurrence remain unclear.
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
GIANNINI, EDOARDO GIOVANNI;
2017-01-01
Abstract
In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma (HCC), the time to HCC recurrence and the effects of sustained viral eradication (SVR) by interferon (IFN)-based or IFN-free regimens on HCC recurrence remain unclear.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
APT & ITALICA 4.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
271.04 kB
Formato
Adobe PDF
|
271.04 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
